Clinical significance of high monocyte counts for the continuous treatment with nintedanib

BACKGROUND: Nintedanib is now widely used to treat interstitial lung disease (ILD). Adverse events, which occur in not a few patients, make it difficult to continue nintedanib treatment, but the risk factors for adverse events are not well understood. METHODS: In this retrospective cohort study, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuneyoshi, Shingo, Zaizen, Yoshiaki, Tominaga, Masaki, Matama, Goushi, Umemoto, Shushi, Ohno, Shuuhei, Takaki, Reiko, Yano, Ryo, Murotani, Kenta, Okamoto, Masaki, Hoshino, Tomoaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318667/
https://www.ncbi.nlm.nih.gov/pubmed/37400801
http://dx.doi.org/10.1186/s12890-023-02536-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318667/
https://www.ncbi.nlm.nih.gov/pubmed/37400801
http://dx.doi.org/10.1186/s12890-023-02536-y

Ejemplares similares